共 46 条
[1]
Nehara HR(2021)Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: case series from the north-western part of India Indian J Med Microbiol S0255-0857 04111-04116
[2]
Puri I(2020)Rhino-orbital mucormycosis associated with COVID-19 Cureus. 12 e10726-2053
[3]
Singhal V(2020)Invasive fungal diseases during COVID-19: we should be prepared J Mycol Med 30 100971-1584
[4]
Ih S(2007)Bouza E; MYCOMED Zygomycosis Study Group. Impact of zygomycosis on microbiology workload: a survey study in Spain J Clin Microbiol 45 2051-722
[5]
Bishnoi BR(2021)Oral candidiasis of COVID-19 patients: case report and review of evidence J Cosmet Dermatol 20 1580-757
[6]
Sirohi P(2020)Epidemiology and diagnosis of mucormycosis: an update J Fungi (Basel) 6 265-undefined
[7]
Mehta S(2012)The deferasirox-ambisome therapy for mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial J Antimicrob Chemother 67 715-undefined
[8]
Pandey A(2016)Breaking the mold: a review of mucormycosis and current pharmacological treatment options Ann Pharmacother 50 747-undefined
[9]
Gangneux JP(2020)IL-6 inhibition in critically Ill COVID-19 patients is associated with increased secondary infections Front Med (Lausanne) 7 583897-undefined
[10]
Bougnoux ME(undefined)undefined undefined undefined undefined-undefined